A higher dependency on glutamine-related ROS detoxyfication activity has been reported for KRAS/LKB1/KEAP1 triple mutants compared to KRAS/LKB1- or KRAS-mutated NSCLC (44). This evidence concerns the gene KRAS and non-small cell lung carcinoma.